ClariVest Asset Management LLC Trims Position in UnitedHealth Group Incorporated (NYSE:UNH)

ClariVest Asset Management LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 36.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,755 shares of the healthcare conglomerate’s stock after selling 4,533 shares during the quarter. ClariVest Asset Management LLC’s holdings in UnitedHealth Group were worth $3,949,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Signature Resources Capital Management LLC increased its stake in UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 18 shares during the period. Saxony Capital Management LLC raised its stake in shares of UnitedHealth Group by 3.5% during the 2nd quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after purchasing an additional 18 shares in the last quarter. GoalVest Advisory LLC grew its stake in shares of UnitedHealth Group by 0.6% in the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after buying an additional 18 shares in the last quarter. Continuum Advisory LLC raised its position in UnitedHealth Group by 0.6% during the second quarter. Continuum Advisory LLC now owns 3,410 shares of the healthcare conglomerate’s stock valued at $1,737,000 after acquiring an additional 19 shares in the last quarter. Finally, Veracity Capital LLC increased its stake in shares of UnitedHealth Group by 1.5% during the 1st quarter. Veracity Capital LLC now owns 1,335 shares of the healthcare conglomerate’s stock worth $660,000 after purchasing an additional 20 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on UNH shares. UBS Group increased their target price on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. HSBC upped their price objective on shares of UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. JPMorgan Chase & Co. boosted their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. Finally, StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $614.17.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $599.04 on Wednesday. The firm has a market cap of $553.17 billion, a P/E ratio of 36.62, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94. The firm’s 50-day simple moving average is $562.99 and its 200-day simple moving average is $516.05.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. The business had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. UnitedHealth Group’s revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the company earned $6.14 EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.40%. The ex-dividend date of this dividend is Monday, September 16th. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.